Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues

Autor: Chetiya Danthanawanit, Yannawan Wongchai, Puttarakun Meesiri, Sutthirat Udommethaporn, Nunthawut Chat-Uthai, Naravat Poungvarin, Shanop Shuangshoti, Pichpisith Vejvisithsakul, Chinachote Teerapakpinyo
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Male
endocrine system diseases
Colorectal cancer
Thai People
Mutagenesis and Gene Deletion Techniques
DNA Mutational Analysis
Gene Identification and Analysis
Oligonucleotides
lcsh:Medicine
Artificial Gene Amplification and Extension
medicine.disease_cause
Polymerase Chain Reaction
Biochemistry
law.invention
0302 clinical medicine
law
Medicine and Health Sciences
Missense mutation
Ethnicities
lcsh:Science
Polymerase chain reaction
Mutation
Multidisciplinary
Nucleotides
Melanoma
Middle Aged
Thailand
Oncology
030220 oncology & carcinogenesis
Female
Colorectal Neoplasms
Research Article
Proto-Oncogene Proteins B-raf
Substitution Mutation
Mutation
Missense

Biology
Research and Analysis Methods
Proto-Oncogene Proteins p21(ras)
03 medical and health sciences
medicine
Genetics
Humans
Molecular Biology Techniques
neoplasms
Mutation Detection
Molecular Biology
Aged
Colorectal Cancer
Point mutation
lcsh:R
Cancer
Biology and Life Sciences
Cancers and Neoplasms
medicine.disease
digestive system diseases
030104 developmental biology
Mutational Analysis
HEK293 Cells
Amino Acid Substitution
People and Places
Mutation testing
Cancer research
lcsh:Q
Population Groupings
Zdroj: PLoS ONE
PLoS ONE, Vol 13, Iss 6, p e0198795 (2018)
ISSN: 1932-6203
Popis: The protein kinase BRAF is one of the key players in regulating cellular responses to extracellular signals. Somatic mutations of the BRAF gene, causing constitutive activation of BRAF, have been found in various types of human cancers such as malignant melanoma, and colorectal cancer. BRAF V600E and V600K, most commonly observed mutations in these cancers, may predict response to targeted therapies. Many techniques suffer from a lack of diagnostic sensitivity in mutation analysis in clinical samples with a low cancer cell percentage or poor-quality fragmented DNA. Here we present allele-specific real-time PCR assay for amplifying 35- to 45-base target sequences in BRAF gene. Forward primer designed for BRAF V600E detection is capable of recognizing both types of BRAF V600E mutation, i.e. V600E1 (c.1799T>A) and V600E2 (c.1799_1800delTGinsAA), as well as complex tandem mutation caused by nucleotide changes in codons 600 and 601. We utilized this assay to analyze Thai formalin-fixed paraffin-embedded tissues. Forty-eight percent of 178 Thai colorectal cancer tissues has KRAS mutation detected by highly sensitive commercial assays. Although these DNA samples contain low overall yield of amplifiable DNA, our newly-developed assay successfully revealed BRAF V600 mutations in 6 of 93 formalin-fixed paraffin-embedded colorectal cancer tissues which KRAS mutation was not detected. Ultra-short PCR assay with forward mutation-specific primers is potentially useful to detect BRAF V600 mutations in highly fragmented DNA specimens from cancer patients.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje